Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Merck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion
Read More
AstraZeneca PLC
Cerebras IPO has ‘too much hair’ as AI chipmaker tries to sell Wall Street on Nvidia alternative
Cerebras is playing in a huge market with insatiable investor demand, but its IPO prospectus is littered with red flags
Read More
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
Bristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested some $10 billion on promising cancer technology behind
Read More
India and Singapore agree to cooperate on chips as countries seek to strengthen partnership
"Singapore is not just a partner, it is an inspiration for every developing country. We want to create a bunch
Read More
India’s Modi expected to usher in new era of bilateral agreements in Singapore visit
The Indian prime minister had also visited Italy, Russia, Ukraine, Poland and Brunei in the last three months since his
Read More
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
It is a milestone in a controversial process that aims to make costly medications more affordable for older Americans but
Read More
These low-volatility stocks have a winning record and are attractively valued
For investors who want to find safe plays amid a volatile market, there's a whole set of large-cap names —
Read More
How to invest $100,000 when stocks are at all-time highs? Here’s what two wealth managers say
One of the pros recommends a stock which currently offers a 6.6% dividend yield. Source link
Read More
This up-and-coming cancer treatment could be a $25 billion market opportunity — it’s already a hotbed for M&A
Targeted radiopharmaceuticals, which deliver radiation directly into tumors, has caught the eye of big pharma. Source link
Read More